Secondary analysis of VITAL-AF (30,265 patients ≥65): 29% of 988 incident AF cases were stressor-associated. Oral anticoagulation within 90 days was lower than for primary AF (56% vs 75%); bleeding, stroke or death risk was high in both (HR 6.13, 3.91 vs no AF).
Secondary analysisn = 30,265
Haimovich et al. Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial